Tesofensine: The Future of Weight Loss?
Science

Tesofensine: The Future of Weight Loss?

Forget GLP-1s. Tesofensine works on Dopamine, Serotonin, and Noradrenaline. It suppresses appetite while boosting metabolism and mood.

ByPeptide Bioregulator Atlas
May 14, 2024
10 min read

Table of Contents

The Triple Reuptake Inhibitor

Tesofensine is not a peptide; it's a small molecule originally explored for Parkinson's/Alzheimer's. It acts as a Triple Reuptake Inhibitor (TRI), increasing levels of:

  1. Dopamine: Motivation and Pleasure.
  2. Serotonin: Mood and Satiety.
  3. Noradrenaline: Energy and Metabolism.

Why It's Unique

GLP-1s (Ozempic) make you physically full (slow gastric emptying). Tesofensine makes you not care about food. It turns off the "reward seeking" behavior.

  • Metabolic Burn: It creates a significant increase in resting energy expenditure (thermogenesis).
  • Mood: Users often report feeling "euphoric" rather than the lethargy associated with dieting.

Clinical Data

In trials, a 0.5mg dose resulted in ~10% weight loss over 24 weeks, comparable to early GLP-1 results but with a completely different mechanism.

Warning

Because it affects Noradrenaline, it can raise heart rate and blood pressure. It is not for those with cardiovascular issues.

Share this article